SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE DOSES OF THE TRPV1 ANTAGONIST SAF312 IN HEALTHY SUBJECTS

被引：0
|
作者：
El Mouelhi, M. [1 ]
Bartlett, M. [2 ]
Roberts, J. [3 ]
Vaidya, S. [4 ]
机构：
[1] Novartis Inst BioMed Res Inc, E Hanover, NJ USA
[2] Novartis Inst BioMed Res Inc, Basel, Switzerland
[3] Novartis, E Hanover, NJ USA
[4] Novartis Inst BioMed Res Inc, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects
    Tiffany, Courtney
    Dumont, Etienne F.
    Hossain, Mohammad
    Srinivasan, Meenakshi
    Swift, Brandon
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (09): : 2251 - 2264
  • [32] PHARMACOKINETICS, TOLERABILITY AND SAFETY OF ABT-530 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY SUBJECTS.
    Lin, C.
    Dutta, S.
    Clifton, J., II
    Asatryan, A.
    Campbell, A.
    Liu, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S69 - S69
  • [33] Safety, tolerability, pharmacokinetics and pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects.
    Marino, MR
    Langenbacher, KM
    Ford, NF
    Uderman, HD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII53 - PII53
  • [34] SAFETY/TOLERABILITY AND PHARMACOKINETICS OF MULTIPLE ORAL DOSES OF APREMILAST IN HEALTHY MALE SUBJECTS
    Wu, A.
    Rohane, P.
    Ng, J.
    DeGroot, B.
    Colgan, B.
    Laskin, O. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S26 - S26
  • [35] Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
    Groenendaal-van de Meent, Dorien
    den Adel, Martin
    van Dijk, Jan
    Barroso-Fernandez, Begona
    El Galta, Rachid
    Golor, Georg
    Schaddelee, Marloes
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (06) : 685 - 692
  • [36] Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects
    Yan, Jing-He
    Bifano, Marc
    Olsen, Steven
    Smith, Robert A.
    Zhang, Duxi
    Grasela, Dennis M.
    LaCreta, Frank
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1250 - 1258
  • [37] Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
    Dorien Groenendaal-van de Meent
    Martin den Adel
    Jan van Dijk
    Begona Barroso-Fernandez
    Rachid El Galta
    Georg Golor
    Marloes Schaddelee
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 685 - 692
  • [38] Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses
    Rolan, Paul
    Gibbons, Jacqueline A.
    He, Lin
    Chang, Eppie
    Jones, Drew
    Gross, Matthew I.
    Davidson, Jennifer Bahr
    Sanftner, Laura M.
    Johnson, Kirk W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (06) : 792 - 801
  • [39] Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
    Naik, Himanshu
    Steiner, Deb J.
    Versavel, Mark
    Palmer, Joanne
    Fong, Regan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1272 - 1279
  • [40] Safety, tolerability and pharmacokinetics (PK) of multiple doses of lecozotan, a novel 5HT1A antagonist, in healthy elderly subjects.
    Parks, V
    Raje, SV
    Patat, AA
    Plotka, A
    Astruc, B
    Chassard, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P68 - P68
12345